semaglutide generic india title Today we launch, Obeda®, India's first DCGI-approved injection for Type 2 Diabetes. This product reinforces our purpose of good health cant wait, to bring high quality and affordable treatment Natco Pharma to Launch Generic

Thanks to its structural modifications, Semaglutide offers extended activity compared to natural GLP-1, enabling the investigation of prolonged receptor interactions and regulatory feedback mechanisms

Both medications work by mimicking the GLP-1 hormone, which helps regulate appetite, reduce hunger, and promote feelings of fullness, leading to decreased calorie consumption and weight loss

The medications full effects can take up to eight weeks to result in noticeable weight loss, but every patient is different, and some notice results sooner or later than that

[2] Cancer [edit] Abdominal obesity has been associated with an increased risk of several cancers, particularly malignancies of the digestive system